VCYT Veracyte, Inc.
$24.16
Veracyte, Inc. (VCYT) Earnings News
Earnings press releases, previews and reviews for Veracyte, Inc. (VCYT), newest first. Our most recent is review: Veracyte Matches the Whisper, but a Decipher Reset and a Soft 2027 Preview Overshadow the Quarter.
Wednesday
November 4, 2026
7:21 PM ET
Veracyte Matches the Whisper, but a Decipher Reset and a Soft 2027 Preview Overshadow the Quarter
Earnings Whispers · Review
Wednesday
November 4, 2026
4:05 PM ET
Veracyte Announces Third Quarter 2026 Financial Results
Tuesday
October 27, 2026
8:24 PM ET
Veracyte's Third Raise Meets a Skeptical Crowd as Prosigna Launch Faces First Test
Earnings Whispers · Preview
Wednesday
October 14, 2026
4:05 PM ET
Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026
Monday
September 14, 2026
4:05 PM ET
Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
Thursday
July 30, 2026
4:05 PM ET
Veracyte Announces Second Quarter 2026 Financial Results
Thursday
July 9, 2026
4:05 PM ET
Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026